NO20013085L - Phosphorus-organic compounds and their use - Google Patents

Phosphorus-organic compounds and their use

Info

Publication number
NO20013085L
NO20013085L NO20013085A NO20013085A NO20013085L NO 20013085 L NO20013085 L NO 20013085L NO 20013085 A NO20013085 A NO 20013085A NO 20013085 A NO20013085 A NO 20013085A NO 20013085 L NO20013085 L NO 20013085L
Authority
NO
Norway
Prior art keywords
group
bio
substituents
hydroxamic acid
phosphorus
Prior art date
Application number
NO20013085A
Other languages
Norwegian (no)
Other versions
NO20013085D0 (en
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of NO20013085D0 publication Critical patent/NO20013085D0/en
Publication of NO20013085L publication Critical patent/NO20013085L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/62Isoquinoline or hydrogenated isoquinoline ring systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • A01N57/24Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds containing heterocyclic radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Fosfororganiske forbindelser med den generelle formel (I), o II P- R< (D hvor A er valgt blant Ci-9-alkylen- grupper, -C-O-C- og -C-N-C-, eller A har svarer til formel (II), 1' f7 ?' (IQ B2 B« Be Ba Bio hvor ett eller flere karbonatomer valgt fra gruppen bestående av C3, C4, Cs også kan være fraværende sammen med sine substituenter, og minst en av substitu- entene fra BI til BIO er en C3.e-syklo- alkyl-(Co-g)-alkylgruppe, samt hvor RI er valgt blant S- og 6-leddede heterosyk- luser med minst ett nitrogenatom i ringen eller polysykliske hydrokarbon- forbindelser inneholdende minst en av disse heterosykluser, idet minst ett av disse nitrogenatomer hører til en hydroksaminsyregruppe eller en hydroks- aminsyreestergruppe. Forbindelsene er anvendbare for terapeutisk og forebyg- gende behandling av infeksjoner hos mennesker og dyr som forårsakes av virus, bakterier, fungi og parasitter, og som fungicider, baktericider og herbicider overfor planter.Phosphorus inorganic compounds of general formula (I), o II P- R <(D where A is selected from C 1-9 alkylene groups, -COC- and -CNC-, or A is similar to formula (II), 1 'f7?' (IQ B2 B «Be Ba Bio where one or more carbon atoms selected from the group consisting of C3, C4, Cs may also be absent together with their substituents, and at least one of the substituents from BI to BIO is a C3 .e-cycloalkyl (Co-g) alkyl group, and wherein R 1 is selected from S and 6 membered heterocycles with at least one nitrogen atom in the ring or polycyclic hydrocarbon compounds containing at least one of these heterocycles, with at least one of these nitrogen atoms belongs to a hydroxamic acid group or a hydroxamic acid ester group The compounds are useful in the therapeutic and preventive treatment of human and animal infections caused by viruses, bacteria, fungi and parasites .

NO20013085A 1998-12-22 2001-06-21 Phosphorus-organic compounds and their use NO20013085L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859426A DE19859426A1 (en) 1998-12-22 1998-12-22 Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections
PCT/EP1999/010274 WO2000037477A1 (en) 1998-12-22 1999-12-22 Organo-phosphorus compounds and their utilization

Publications (2)

Publication Number Publication Date
NO20013085D0 NO20013085D0 (en) 2001-06-21
NO20013085L true NO20013085L (en) 2001-08-22

Family

ID=7892237

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013085A NO20013085L (en) 1998-12-22 2001-06-21 Phosphorus-organic compounds and their use

Country Status (25)

Country Link
EP (1) EP1140952B1 (en)
JP (1) JP2002533350A (en)
KR (1) KR20010089670A (en)
CN (1) CN1331695A (en)
AP (1) AP2001002168A0 (en)
AT (1) ATE248846T1 (en)
AU (1) AU2538500A (en)
BR (1) BR9916466A (en)
CA (1) CA2356289A1 (en)
CZ (1) CZ20012284A3 (en)
DE (2) DE19859426A1 (en)
DK (1) DK1140952T3 (en)
EA (1) EA200100689A1 (en)
ES (1) ES2204189T3 (en)
HU (1) HUP0104866A3 (en)
IL (1) IL143470A0 (en)
MX (1) MXPA01006456A (en)
NO (1) NO20013085L (en)
OA (1) OA11730A (en)
PL (1) PL349045A1 (en)
PT (1) PT1140952E (en)
SK (1) SK8892001A3 (en)
TR (1) TR200101832T2 (en)
WO (1) WO2000037477A1 (en)
ZA (1) ZA200104443B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002078714A1 (en) * 2001-03-30 2002-10-10 Jomaa Pharmaka Gmbh Formulations which are resistant to gastric juice and are used to apply anti-infective compounds inhibiting the 2-c-methylerythrose-4 metabolic pathway, and the salts and esters of the same
WO2008040097A1 (en) * 2006-10-06 2008-04-10 Biosignal Limited Furanone compounds and lactam analogues thereof
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
US8993542B2 (en) 2008-01-25 2015-03-31 Chimerix Inc. Methods of treating viral infections
US9006218B2 (en) 2010-02-12 2015-04-14 Chimerix Inc. Nucleoside phosphonate salts
AU2011248620B2 (en) 2010-04-26 2015-11-26 Chimerix, Inc. Methods of treating retroviral infections and related dosage regimes
PL3010511T3 (en) 2014-09-12 2018-07-31 Antibiotx A/S Antibacterial use of halogenated salicylanilides
HUE058190T2 (en) * 2015-03-09 2022-07-28 Univ Texas Enolase inhibitors and methods of treatment therewith
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206156A (en) * 1976-07-27 1980-06-03 Fujisawa Pharmaceutical Company, Limited Hydroxyaminohydrocarbonphosphonic acids
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
JPS61106504A (en) * 1984-10-30 1986-05-24 Teijin Ltd Herbicide
CN1297352A (en) * 1998-04-14 2001-05-30 哈桑·朱马 Use of organophosphoric compounds for therapeutic and preventative treatment of infections

Also Published As

Publication number Publication date
WO2000037477A1 (en) 2000-06-29
EP1140952A1 (en) 2001-10-10
NO20013085D0 (en) 2001-06-21
ZA200104443B (en) 2002-01-14
CN1331695A (en) 2002-01-16
AU2538500A (en) 2000-07-12
HUP0104866A2 (en) 2002-06-29
ATE248846T1 (en) 2003-09-15
ES2204189T3 (en) 2004-04-16
CZ20012284A3 (en) 2001-10-17
EA200100689A1 (en) 2001-12-24
IL143470A0 (en) 2002-04-21
PL349045A1 (en) 2002-07-01
KR20010089670A (en) 2001-10-08
MXPA01006456A (en) 2002-04-24
BR9916466A (en) 2001-09-25
AP2001002168A0 (en) 2001-06-30
DK1140952T3 (en) 2004-01-12
PT1140952E (en) 2004-02-27
OA11730A (en) 2005-05-12
CA2356289A1 (en) 2000-06-29
DE19859426A1 (en) 2000-07-06
HUP0104866A3 (en) 2002-08-28
EP1140952B1 (en) 2003-09-03
SK8892001A3 (en) 2001-12-03
JP2002533350A (en) 2002-10-08
DE59906907D1 (en) 2003-10-09
TR200101832T2 (en) 2001-12-21

Similar Documents

Publication Publication Date Title
TR200200749T2 (en) Quinazoline compounds and pharmaceutical compositions containing them.
BR0207025A (en) Isoxazoline and herbicide derivative containing the same as the active ingredient
BG105271A (en) 1h-imidazopyridine derivatives
BR0309447A (en) Compound, agent, processes for their preparation, and for combating unwanted plant growth, and use of the compound
TR200101298T2 (en) As a fungicide, new pyrimidine-4-enamine
NO20013085L (en) Phosphorus-organic compounds and their use
WO2002062767A1 (en) Novel quinazoline derivatives
TR200100068T2 (en) Phosphorous organic compounds and their uses
ATE497948T1 (en) BICYCLIC COMPOUNDS
MXPA04005940A (en) 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases.
YU44102A (en) Cyclic quaternary ammonium compounds
WO2000066094A3 (en) Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
DE60003671D1 (en) HALO DERIVATIVES OF 9-DEOXO-9A-AZA-9A-HOMERYTHROMYCIN A
NO20013651L (en) Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections
DE60009263D1 (en) 2-ADAMANTANMETHANAMINE COMPOUNDS FOR TREATING DEVIATIONS IN GLUTAMATERGIC TRANSMISSIONS
ATE95815T1 (en) MEANS OF PROTECTING PLANTS AGAINST DISEASES.
PT1059845E (en) FUNGICIDE COMPOSITION UNDERSTANDING A BENZOYLPHENYLURIA
ATE286728T1 (en) USE OF HOMOCYSTEINE DERIVATIVES TO TREAT BACTERIAL INFECTIONS
NO20013464L (en) Use of 3-isoxazolidinones and hydroxylamino acids for the treatment of infections
ES2108254T3 (en) COMPOSITION OF THE INFECTION INHIBITOR WITH AIDS VIRUSES.
TH23898B (en) How to stop the action of IL-6
TH16729A (en) 4-hydroxy-benzopyran-2-transfer and 4- hydroxycloalkylkyl [B] Piran-2-On It is used to treat HIV infection. And retrieving other viruses
TH17773A (en) Acid compounds Asa-Bisphophonic Used as a weed limiting substance
TH23898A (en) How to stop the action of IL-6

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application